✦ LIBER ✦

Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload

✍ Scribed by S. Daar; A. V. Pathare

Publisher: Springer
Year: 2006
Tongue: English
Weight: 102 KB
Volume: 85
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-005-0075-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective comparison on cardiac iron b

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy

✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Marcell 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 290 KB

Combined therapy with deferiprone and de

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major

✍ K.H. Wu; J.S. Chang; C.H. Tsai; C.T. Peng 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 184 KB

A T2* MRI prospective survey on heart ir

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy

✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Luciano 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 284 KB

Pepe et al.: A T2\* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipronedesferrioxamine versus deferipron and desferrioxamine in monotherapy.

Chelation therapy prevents alteration of

Chelation therapy prevents alteration of diastolic function in patients with thalassemia maior in transfusional iron overload

📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 51 KB

Effect of deferiprone or deferoxamine on

Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload

✍ Gillian C Smith; Francisco Alpendurada; John Paul Carpenter; Mohammed H Alam; Va 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 590 KB

## Background Thalassaemia major (TM) patients need regular blood transfusions that lead to accumulation of iron and death from heart failure. Deferiprone has been reported to be superior to deferoxamine for the removal of cardiac iron and improvement in left ventricular (LV) function but little is

A T2* MRI prospective survey on heart ir

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox

✍ Alessia Pepe; Antonella Meloni; Giuseppe Rossi; Maria Chiara Dell’Amico; Domenic 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 147 KB

Pepe et al.: A T2\* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprondesferrioxamine versus deferasirox.